These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 10640842

  • 1. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
    Mommers JM, van Erp PE, van De Kerkhof PC.
    Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
    [Abstract] [Full Text] [Related]

  • 2. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
    van der Vleuten CJ, van Vlijmen-Willems IM, de Jong EM, van de Kerkhof PC.
    Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
    [Abstract] [Full Text] [Related]

  • 3. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment.
    Glade CP, van der Vleuten CJ, van Erp PE, van de Kerkhof PC.
    Skin Pharmacol Appl Skin Physiol; 2002; 15(2):92-9. PubMed ID: 11867965
    [Abstract] [Full Text] [Related]

  • 4. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G, Kragballe K, Van De Kerkhof PC, Aberg K, White RJ.
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [Abstract] [Full Text] [Related]

  • 5. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
    Mommers JM, Goossen JW, van De Kerkhof PC, van Erp PE.
    Cytometry; 2000 Feb 15; 42(1):43-9. PubMed ID: 10679742
    [Abstract] [Full Text] [Related]

  • 6. A clinical and flow cytometric model to study remission and relapse in psoriasis.
    Glade CP, van Erp PE, Werner-Schlenzka H, van de Kerkhof PC.
    Acta Derm Venereol; 1998 May 15; 78(3):180-5. PubMed ID: 9602222
    [Abstract] [Full Text] [Related]

  • 7. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
    Castelijns FA, Gerritsen MJ, van Vlijmen-Willems IM, van Erp PE, van de Kerkhof PC.
    J Am Acad Dermatol; 1999 Jun 15; 40(6 Pt 1):901-9. PubMed ID: 10365920
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of calcipotriol ointment applied under hydrocolloid occlusion in psoriasis.
    Castelijns FA, Gerritsen MJ, van Erp PE, van de Kerkhof PC.
    Dermatology; 2000 Jun 15; 200(1):25-30. PubMed ID: 10681609
    [Abstract] [Full Text] [Related]

  • 9. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
    Mommers JM, van Rossum MM, van Erp PE, van De Kerkhof PC.
    Dermatology; 2000 Jun 15; 201(1):15-20. PubMed ID: 10971053
    [Abstract] [Full Text] [Related]

  • 10. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
    Broby-Johansen U, Karlsmark T, Petersen LJ, Serup J.
    Clin Exp Dermatol; 1990 Sep 15; 15(5):343-8. PubMed ID: 2225536
    [Abstract] [Full Text] [Related]

  • 11. Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression.
    Franssen ME, Boezeman JB, Van De Kerkhof PC, Van Erp PE.
    Cytometry B Clin Cytom; 2004 Jan 15; 57(1):32-9. PubMed ID: 14696061
    [Abstract] [Full Text] [Related]

  • 12. Use of a hydrocolloid dressing in combination with a topical steroid in plaque psoriasis.
    Theeuwes M, Bright R.
    Cutis; 1996 Jan 15; 57(1):48-50. PubMed ID: 8620686
    [Abstract] [Full Text] [Related]

  • 13. VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.
    Mommers JM, Van Rossum MM, Kooijmans-Otero ME, Parker GL, van de Kerkhof PC.
    Br J Dermatol; 2000 Feb 15; 142(2):259-66. PubMed ID: 10730758
    [Abstract] [Full Text] [Related]

  • 14. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.
    J Eur Acad Dermatol Venereol; 1998 Jul 15; 11(1):19-24. PubMed ID: 9731961
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing.
    Volden G.
    Acta Derm Venereol; 1992 Jul 15; 72(1):69-71. PubMed ID: 1350154
    [Abstract] [Full Text] [Related]

  • 16. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
    Nissen JB, Avrach WW, Hansen ES, Stengaard-Pedersen K, Kragballe K.
    Dermatology; 1999 Jul 15; 198(1):11-7. PubMed ID: 10026395
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques.
    Ilknur T, Akarsu S, Aktan S, Ozkan S.
    Dermatol Surg; 2006 Jan 15; 32(1):49-55. PubMed ID: 16393598
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis.
    Kragballe K, Larsen FG.
    Acta Derm Venereol; 1991 Jan 15; 71(6):540-2. PubMed ID: 1685841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.